PetCure Oncology marks 3,000 cancer treatmentsSeptember 26, 2019Cancer care company PetCure Oncology hit a milestone this week with the treatment of its 3,000th patient.
SPONSORED CONTENTLife-saving results for parvovirus casesResearch has shown that puppies treated with our Canine Parvovirus Monoclonal Antibody have shorter clinic stays.1 Transform parvo treatment outcomes for your patients. + Read More
Cancer treatment company plans for public offeringJuly 25, 2019PetCure Oncology has engaged Boustead Securities for a Regulation D 506(c) offering.